Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Global Health Limited (MEDANTA.NS)
Gurugram, IN
Operating throughout India, Global Health Limited, known by its Medanta brand, stands as a prominent multi-specialty tertiary care provider. The company delivers a comprehensive suite of healthcare services, with particular expertise in cardiology, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplantation, as well as kidney and urology treatments. Established in 2004 and headquartered in Gurgaon, India, it operates a network of four hospitals strategically located in Gurugram, Indore, Ranchi, and Lucknow.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.15% | +3.62% | +13.63% | +5.59% | +2.98% | +4.34% | +4.82% | +119.41% | +198.07% | +198.07% | +198.07% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | -1 |
| Buy | 8 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+21.3% ★ Q1'26: +32.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+15.3% Q1'26: +41.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+8.4% Q1'26: -7.3% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+15.8% ★ Q1'26: +15.3% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+13.4% ★ Q1'26: +13.3% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.3% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.29× ★ Q1'26: 1.22× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 14 Rev. Ana. 10 EPS Ana. |
Mar 2027 11 Rev. Ana. 10 EPS Ana. |
Mar 2028 14 Rev. Ana. 13 EPS Ana. |
Mar 2029 3 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
26.83B
est: 26.80B (+0.1%)
|
32.41B
est: 33.57B (-3.4%)
|
36.37B
est: 37.10B (-2.0%)
|
43.76B
43.16B – 44.44B
+17.9% YoY
|
50.49B
49.49B – 51.47B
+15.4% YoY
|
58.21B
54.22B – 62.48B
+15.3% YoY
|
65.17B
63.02B – 67.33B
+12.0% YoY
|
78.41B
74.80B – 82.20B
+20.3% YoY
|
| EBITDA |
6.77B
est: 6.10B (+11.0%)
|
8.72B
est: 8.09B (+7.9%)
|
9.05B
est: 8.94B (+1.2%)
|
10.54B
10.40B – 10.71B
+17.9% YoY
|
12.16B
11.92B – 12.40B
+15.4% YoY
|
14.02B
13.06B – 15.05B
+15.3% YoY
|
15.70B
15.18B – 16.22B
+12.0% YoY
|
18.89B
18.02B – 19.80B
+20.3% YoY
|
| EBIT |
5.27B
est: 4.45B (+18.3%)
|
7.00B
est: 6.26B (+11.8%)
|
7.11B
est: 6.92B (+2.9%)
|
8.16B
8.04B – 8.28B
+17.9% YoY
|
9.41B
9.22B – 9.59B
+15.4% YoY
|
10.85B
10.10B – 11.64B
+15.3% YoY
|
12.15B
11.74B – 12.55B
+12.0% YoY
|
14.61B
13.94B – 15.32B
+20.3% YoY
|
| Net Income |
3.26B
est: 3.17B (+2.8%)
|
4.78B
est: 4.82B (-0.9%)
|
4.81B
est: 5.34B (-9.9%)
|
5.56B
5.23B – 5.88B
+4.2% YoY
|
6.84B
6.65B – 7.29B
+22.9% YoY
|
8.37B
7.73B – 9.48B
+22.4% YoY
|
9.33B
8.94B – 9.35B
+11.5% YoY
|
9.21B
8.66B – 9.79B
-1.3% YoY
|
| SGA |
4.29B
est: 3.28B (+30.6%)
|
5.40B
est: 6.42B (-15.9%)
|
6.41B
est: 7.09B (-9.6%)
|
8.37B
8.25B – 8.50B
+17.9% YoY
|
9.65B
9.46B – 9.84B
+15.4% YoY
|
11.13B
10.37B – 11.95B
+15.3% YoY
|
12.46B
12.05B – 12.87B
+12.0% YoY
|
14.99B
14.30B – 15.72B
+20.3% YoY
|
| EPS |
12.58
est: 11.91 (+5.6%)
|
17.80
est: 17.96 (-0.9%)
|
17.92
est: 19.78 (-9.4%)
|
20.40
19.40 – 21.82
+3.2% YoY
|
25.58
24.67 – 27.08
+25.4% YoY
|
31.56
28.70 – 35.20
+23.4% YoY
|
33.97
33.21 – 34.73
+7.6% YoY
|
34.19
32.15 – 36.34
+0.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree India Earnings Fund EPI | 0.01% | 237.9K | 0.84% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Naresh Kumar Trehan | Chairman & MD | 62M | — |
| Pankaj Prakash Sahni | Group Chief Executive Officer & Additional Whole Time Director | 52M | male |
| Yogesh Kumar Gupta | Chief Financial Officer | 23M | male |
| Bhuvander Kaul | Chief Procurement Officer | — | male |
| Richa Singh | General Counsel | — | female |
| Sandeep Sawhney | Chief Strategy Officer | — | — |
| Saurabh Upadhyay | Senior Vice President & Head of Human Resources | — | male |
| Rajiv Sikka | Chief Information Officer | — | male |
| Kedar Apte | Chief Marketing & Growth Officer | — | male |
| Rahul Ranjan | Company Secretary & Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MEDANTA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
